Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Growth save search
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.5%
H: 6.09%
C: 5.58%
year ongoing financial results growth hormone
Global $4.1 Billion Clinical Trial Supplies Market Report 2024-2034 - Emerging Markets Catalyzing Growth in Clinical Trial Supplies
Published: 2024-03-26 (Crawled : 17:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 0.46%
H: 0.65%
C: -0.43%
report global trial growth market
TransCon™ hGH (lonapegsomatropin) Achieved Statistically Superior Outcomes Compared to Placebo in Phase 3 foresiGHt Trial of Adults with Growth Hormone Deficiency
Published: 2023-12-19 (Crawled : 13:30) - globenewswire.com
ASND | $140.98 -0.84% -0.84% 220K
|
Health Technology
|
| O: 0.99%
H: 1.39%
C: 0.93%
trial growth hormone
Clinical Trial Services Market to Exhibit Significant Growth at 6.11% CAGR, Garnering $72.54 Billion by 2030, with North America Leading the Industry as Demand for Innovative Therapies Rises, States Kings Research
Published: 2023-12-15 (Crawled : 15:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.77%
H: 0.63%
C: -0.84%
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.02%
H: 0.73%
C: 0.66%
MEDP | $374.23 -2.15% -2.19% 220K
|
Commercial Services
|
| O: 0.24%
H: 1.67%
C: 0.27%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 0.6%
H: 0.54%
C: -0.23%
america services research trial growth market
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
Published: 2023-11-21 (Crawled : 21:00) - globenewswire.com
LUMO | News | $2.64 4.76% 4.55% 12K
|
Health Technology
|
| O: -1.64%
H: 4.66%
C: 2.67%
lum-201 pharma treatment trial potential growth hormone
Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | The growth of the biopharmaceutical industry drives the market growth - Technavio
Published: 2023-11-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
trial growth market
United States Clinical Trials Support Services Market Analysis Reprot 2023-2028: Pharma & Biotech Companies Invest Heavily, Phase III Trials Anticipated to Showcase Highest Growth Rate
Published: 2023-10-18 (Crawled : 01:00) - prnewswire.com
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: -1.23%
H: 0.3%
C: -3.38%
pharma companies services biotech trials growth market
Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon™ hGH in Pediatric Growth Hormone Deficiency
Published: 2023-09-23 (Crawled : 12:20) - globenewswire.com
ASND | $140.98 -0.84% -0.84% 220K
|
Health Technology
| Email alert
Add to watchlist
pharma trial results growth hormone
CGC MONDAY DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CGC
Published: 2023-07-22 (Crawled : 20:20) - prnewswire.com
CGC | News | $7.82 20.49% 17.01% 17M
|
Process Industries
| Email alert
Add to watchlist
AER | $83.74 0.18% -0.81% 1.8M
|
Finance
| Email alert
Add to watchlist
corporation deadline trial growth
Global Drug Discovery Services Market Report 2023: Rising Focus on Drug Discovery Trials Bolsters Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 1.0%
H: 0.49%
C: -0.85%
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: 0.87%
H: 1.94%
C: 1.26%
drug services report trials global growth market
Global Clinical Trials Market to 2031: Increasing Number of Clinical Trials and Increase in Demand for Novel Therapies Drives Growth
Published: 2023-05-06 (Crawled : 00:20) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
IQV | $227.17 -0.03% -0.79% 610K
|
Health Services
| Email alert
Add to watchlist
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
| Email alert
Add to watchlist
trials global growth market
Stem Cell Therapy Global Market Report 2022: Advancements in Stem Cell Clinical Trials Fuels Growth
Published: 2023-04-05 (Crawled : 23:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 1.24%
H: 2.42%
C: 1.94%
report cell trials global therapy growth market
QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
Published: 2023-03-20 (Crawled : 14:00) - biospace.com/
QSAM | $7.4 -31.58% 3.7K
|
Manufacturing
|
| O: -4.48%
H: 7.41%
C: 7.41%
conference trial growth
Medical Affairs Outsourcing Global Market Report 2023: Increasing Number of Clinical Trials Fuels Growth
Published: 2023-03-14 (Crawled : 02:00) - prnewswire.com
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 1.51%
H: 2.1%
C: 0.13%
trials global report medical growth market
Clinical trial management system (CTMS) market size to increase by USD 1,449.16 million between 2022 and 2027; Growth driven by increasing healthcare expenditure - Technavio
Published: 2023-03-11 (Crawled : 08:20) - prnewswire.com
VEEV | News | $199.54 0.17% -0.27% 850K
|
Technology Services
| Email alert
Add to watchlist
management system trial growth market
Hoth Therapeutics Announces Collaboration with First Active Clinical Site for its Phase 2 Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published: 2023-03-08 (Crawled : 17:00) - biospace.com/
HOTH | $1.23 0.0% 20K
|
Health Technology
|
| O: -0.37%
H: 4.49%
C: 2.62%
active collaboration trial therapeutics therapy cancer growth
Hoth Therapeutics Announces Selection of First 3 Clinical Sites for its Phase 2 Clinical Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published: 2023-01-25 (Crawled : 15:20) - biospace.com/
HOTH | $1.23 0.0% 20K
|
Health Technology
|
| O: -1.76%
H: 2.79%
C: 2.79%
trial therapeutics therapy cancer growth
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
LUMO | News | $2.64 4.76% 4.55% 12K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -34.39%
lum-201 pharma trials growth hormone
Digital Biomarkers Drug Development Market Report 2022: Transformational Growth for Clinical Trials via Enhancements to Patient Recruitment, Stratification, Monitoring, and Drug Response Comprehension
Published: 2022-08-17 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -6.7%
H: 1.01%
C: 0.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.42%
H: 0.0%
C: 0.0%
trials drug report response biomarkers growth market
Genexine Announces Completion of Enrollment in Phase 3 Clinical Trial with Its Proprietary Long-acting Growth Hormone, GX-H9/TJ101 (Eftansomatropin alfa)
Published: 2022-06-14 (Crawled : 10:00) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: -3.71%
H: 0.0%
C: 0.0%
tj101 trial growth phase 3
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.